Methylenedioxyphentermine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Methylenedioxyphentermine
Methylenedioxyphentermine.svg
Names
IUPAC name
2-Benzo[1,3]dioxol-5-yl-1,1-dimethylethylamine
Other names
3,4-Methylenedioxyphentermine;
3,4-Methylenedioxy-alpha,alpha-dimethyl-1-ethane
Identifiers
39235-63-7 YesY
ChemSpider 15204207 N
Jmol 3D model Interactive image
  • InChI=1S/C11H15NO2/c1-11(2,12)6-8-3-4-9-10(5-8)14-7-13-9/h3-5H,6-7,12H2,1-2H3 N
    Key: OIZBHKBNZXRXSM-UHFFFAOYSA-N N
  • InChI=1/C11H15NO2/c1-11(2,12)6-8-3-4-9-10(5-8)14-7-13-9/h3-5H,6-7,12H2,1-2H3
    Key: OIZBHKBNZXRXSM-UHFFFAOYAY
  • NC(C)(C)CC1=CC(OCO2)=C2C=C1
Properties
C11H15NO2
Molar mass 193.24
Vapor pressure {{{value}}}
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

3,4-Methylenedioxyphentermine (MDPH) is a lesser-known psychedelic drug. MDPH was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 160–240 mg, and the duration as 3–5 hours. MDPH's effects are very similar to those of MDA: they both are smooth and "stoning," and do not cause any visuals. They also alter dreams and dream patterns. Shulgin describes MDPH as a promoter; it promotes the effects of other drugs, similarly to 2C-D. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPH.

See also

References

Lua error in package.lua at line 80: module 'strict' not found.

External links


<templatestyles src="Asbox/styles.css"></templatestyles>